391 related articles for article (PubMed ID: 25174822)
1. Assessment of renal function during high-dose methotrexate treatment in children with acute lymphoblastic leukemia.
Ylinen E; Jahnukainen K; Saarinen-Pihkala UM; Jahnukainen T
Pediatr Blood Cancer; 2014 Dec; 61(12):2199-202. PubMed ID: 25174822
[TBL] [Abstract][Full Text] [Related]
2. Serum cystatin C and serum and urine NGAL in the kidney function assessment of patients with MGUS.
Stelmach-Goldys A; Czarkowska-Paczek B; Wyczalkowska-Tomasik A; Paczek L
Eur J Haematol; 2015 Feb; 94(2):162-8. PubMed ID: 25046079
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil gelatinase-associated lipocalin and cystatin C could predict renal outcome in patients undergoing kidney allograft transplantation: a prospective study.
Lebkowska U; Malyszko J; Lebkowska A; Koc-Zorawska E; Lebkowski W; Malyszko JS; Kowalewski R; Gacko M
Transplant Proc; 2009; 41(1):154-7. PubMed ID: 19249501
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy, side effects and blood concentration monitoring of high-dose methotrexate in treatment of 180 children with acute lymphoblastic leukemia].
Wang H; Chi ZF; Li S; Wang XL; Hao LC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):949-52. PubMed ID: 21867621
[TBL] [Abstract][Full Text] [Related]
5. Serum neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for predicting high dose methotrexate associated acute kidney injury in children with acute lymphoblastic leukemia.
Li H; Xu Q; Wang Y; Chen K; Li J
Cancer Chemother Pharmacol; 2020 Jan; 85(1):95-103. PubMed ID: 31676986
[TBL] [Abstract][Full Text] [Related]
6. Urinalysis is more specific and urinary neutrophil gelatinase-associated lipocalin is more sensitive for early detection of acute kidney injury.
Schinstock CA; Semret MH; Wagner SJ; Borland TM; Bryant SC; Kashani KB; Larson TS; Lieske JC
Nephrol Dial Transplant; 2013 May; 28(5):1175-85. PubMed ID: 22529161
[TBL] [Abstract][Full Text] [Related]
7. Plasma neutrophil-gelatinase-associated lipocalin and cystatin C could early diagnose contrast-induced acute kidney injury in patients with renal insufficiency undergoing an elective percutaneous coronary intervention.
Liu XL; Wang ZJ; Yang Q; Yu M; Shen H; Nie B; Han HY; Gao F; Zhou YJ
Chin Med J (Engl); 2012 Mar; 125(6):1051-6. PubMed ID: 22613530
[TBL] [Abstract][Full Text] [Related]
8. Renal effects of coronary artery bypass graft surgery in diabetic and non-diabetic patients: a study with urinary neutrophil gelatinase-associated lipocalin and serum cystatin C.
Arun O; Celik G; Oc B; Unlu A; Celik JB; Oc M; Duman A
Kidney Blood Press Res; 2015; 40(2):141-52. PubMed ID: 25832128
[TBL] [Abstract][Full Text] [Related]
9. Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery--a prospective cohort study.
Haase-Fielitz A; Bellomo R; Devarajan P; Story D; Matalanis G; Dragun D; Haase M
Crit Care Med; 2009 Feb; 37(2):553-60. PubMed ID: 19114878
[TBL] [Abstract][Full Text] [Related]
10. Urinary neutrophil gelatinase associated lipocalin as a biomarker in ifosfamide induced chronic renal failure.
Kesik V; Demirkaya E; Buyukpamukçu M
Eur Rev Med Pharmacol Sci; 2015 Dec; 19(24):4851-7. PubMed ID: 26744877
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil gelatinase-associated lipocalin (NGAL) in heart transplant recipients after conversion to everolimus therapy.
Stypmann J; Fobker M; Rosing K; Engelen M; Gunia S; Dell'Aquila AM; Nofer JR
J Cardiol; 2015 Oct; 66(4):347-52. PubMed ID: 25583090
[TBL] [Abstract][Full Text] [Related]
12. Serum creatinine and creatinine clearance for predicting plasma methotrexate concentrations after high-dose methotrexate chemotherapy for the treatment for childhood lymphoblastic malignancies.
Xu WQ; Zhang LY; Chen XY; Pan BH; Mao JQ; Song H; Li JY; Tang YM
Cancer Chemother Pharmacol; 2014 Jan; 73(1):79-86. PubMed ID: 24158402
[TBL] [Abstract][Full Text] [Related]
13. High-dose methotrexate: on the relationship of methotrexate elimination time vs renal function and serum methotrexate levels in 1164 courses in 264 Swedish children with acute lymphoblastic leukaemia (ALL).
Skärby T; Jönsson P; Hjorth L; Behrentz M; Björk O; Forestier E; Jarfelt M; Lönnerholm G; Höglund P
Cancer Chemother Pharmacol; 2003 Apr; 51(4):311-20. PubMed ID: 12721759
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil gelatinase-associated lipocalin (NGAL) for the early detection of contrast-induced nephropathy after percutaneous coronary intervention.
Liebetrau C; Gaede L; Doerr O; Blumenstein J; Rixe J; Teichert O; Willmer M; Weber M; Rolf A; Möllmann H; Hamm C; Nef H
Scand J Clin Lab Invest; 2014 Mar; 74(2):81-8. PubMed ID: 24304491
[TBL] [Abstract][Full Text] [Related]
15. Clinical application of neutrophil gelatinase-associated lipocalin in the revised chronic kidney disease classification.
Xiang D; Zhang H; Bai J; Ma J; Li M; Gao J; Wang C
Int J Clin Exp Pathol; 2014; 7(10):7172-81. PubMed ID: 25400814
[TBL] [Abstract][Full Text] [Related]
16. Establishment of reference values for novel urinary biomarkers for renal damage in the healthy population: are age and gender an issue?
Pennemans V; Rigo JM; Faes C; Reynders C; Penders J; Swennen Q
Clin Chem Lab Med; 2013 Sep; 51(9):1795-802. PubMed ID: 23648635
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of plasma neutrophil gelatinase-associated lipocalin for mortality in patients with heart failure.
van Deursen VM; Damman K; Voors AA; van der Wal MH; Jaarsma T; van Veldhuisen DJ; Hillege HL
Circ Heart Fail; 2014 Jan; 7(1):35-42. PubMed ID: 24347663
[TBL] [Abstract][Full Text] [Related]
18. NGAL, L-FABP, and KIM-1 in comparison to established markers of renal dysfunction.
Holzscheiter L; Beck C; Rutz S; Manuilova E; Domke I; Guder WG; Hofmann W
Clin Chem Lab Med; 2014 Apr; 52(4):537-46. PubMed ID: 24243749
[TBL] [Abstract][Full Text] [Related]
19. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in hypertensive and normotensive patients with coronary artery disease.
Malyszko J; Bachorzewska-Gajewska H; Malyszko JS; Pawlak K; Dobrzycki S
Nephrology (Carlton); 2008 Apr; 13(2):153-6. PubMed ID: 18275504
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil gelatinase-associated lipocalin as a follow-up marker in critically ill pediatric patients with established acute kidney injury.
Polat M; Fidan K; Derinöz O; Gönen S; Söylemezoglu O
Ren Fail; 2013; 35(3):352-6. PubMed ID: 23391290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
